Spots Global Cancer Trial Database for autologous stem cell transplantation (ast)
Every month we try and update this database with for autologous stem cell transplantation (ast) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Siltuximab to Decrease Symptom Burden After Autologous Stem Cell Transplantation for Patients With Multiple Myeloma and AL Amyloidosis | NCT03315026 | Multiple Myelom... AL Amyloidosis | Siltuximab The M.D. Anders... | 60 Years - 75 Years | Memorial Sloan Kettering Cancer Center |